Mario Poljak

Author PubWeight™ 91.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 2012 3.09
2 Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis 2009 2.60
3 Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer 2014 1.40
4 European recommendations for the clinical use of HIV drug resistance testing: 2011 update. AIDS Rev 2011 1.38
5 HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. Retrovirology 2013 1.30
6 Pediatric tick-borne encephalitis in 371 cases from an endemic region in Slovenia, 1959 to 2000. Pediatr Infect Dis J 2003 1.20
7 HIV‑1 molecular epidemiology in the Balkans: a melting pot for high genetic diversity. AIDS Rev 2012 1.16
8 Classification and nomenclature system for human Alphapapillomavirus variants: general features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineages. Acta Dermatovenerol Alp Pannonica Adriat 2011 1.14
9 Current review on squamous intraepithelial lesions of the larynx. Histopathology 2008 1.10
10 Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaboration. J Clin Microbiol 2013 1.06
11 Transmission of Mycobacterium tuberculosis from human to cattle. J Clin Microbiol 2005 1.04
12 Complete Genome Sequence of a Novel Human Betapapillomavirus, HPV-159. Genome Announc 2013 1.03
13 Comprehensive control of human papillomavirus infections and related diseases. Vaccine 2013 1.02
14 Limited cross-border infections in patients newly diagnosed with HIV in Europe. Retrovirology 2013 1.01
15 Characterization of human papillomavirus type 120: a novel betapapillomavirus with tropism for multiple anatomical niches. J Gen Virol 2012 0.99
16 Beta-papillomaviruses in anogenital hairs plucked from healthy individuals. J Med Virol 2006 0.98
17 Molecular epidemiology of tuberculosis in Slovenia: results of a one-year (2001) nation-wide study. Scand J Infect Dis 2003 0.98
18 Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infect Dis 2014 0.96
19 Comparison of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for the detection of human papillomaviruses in formalin-fixed, paraffin-embedded cervical cancer specimens. J Virol Methods 2011 0.94
20 Transcription factors Snail, Slug, Twist, and SIP1 in spindle cell carcinoma of the head and neck. Virchows Arch 2009 0.93
21 Current views and perspectives on classification of squamous intraepithelial lesions of the head and neck. Head Neck Pathol 2014 0.92
22 The role of core antigen detection in management of hepatitis C: a critical review. J Clin Virol 2005 0.92
23 Low prevalence of hepatitis B and C infections among HIV-infected individuals in Slovenia: a nation-wide study, 1986-2008. Acta Dermatovenerol Alp Pannonica Adriat 2009 0.92
24 Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping. J Virol Methods 2006 0.91
25 Distribution of human papillomavirus genotypes in plucked eyebrow hairs from Slovenian males with genital warts. Infect Genet Evol 2004 0.91
26 Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes. J Clin Virol 2009 0.91
27 Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. Retrovirology 2012 0.91
28 Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004. Virus Res 2006 0.90
29 Down-regulation of microRNAs of the miR-200 family and miR-205, and an altered expression of classic and desmosomal cadherins in spindle cell carcinoma of the head and neck--hallmark of epithelial-mesenchymal transition. Hum Pathol 2011 0.90
30 Human papillomavirus (HPV) prevalence and HPV type distribution in cervical, vulvar, and anal cancers in central and eastern Europe. Acta Dermatovenerol Alp Pannonica Adriat 2013 0.90
31 Characterization of novel cutaneous human papillomavirus genotypes HPV-150 and HPV-151. PLoS One 2011 0.89
32 Efficacy of chronic hepatitis C therapy with interferon alpha (IFN-alpha) in Slovenia. Hepatogastroenterology 2002 0.89
33 Universal ProbeLibrary based real-time PCR assay for detection and confirmation of human papillomavirus genotype 52 infections. J Virol Methods 2009 0.89
34 GeneXpert enterovirus assay: one-year experience in a routine laboratory setting and evaluation on three proficiency panels. J Clin Microbiol 2008 0.89
35 Comparative evaluation of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for detecting and identifying human papillomaviruses in archival tissue specimens of head and neck cancers. Acta Dermatovenerol Alp Pannonica Adriat 2012 0.88
36 Prevalence and clinical relevance of cagA, vacA, and iceA genotypes of Helicobacter pylori isolated from Slovenian children. J Pediatr Gastroenterol Nutr 2009 0.88
37 Clinical utility of molecular detection of human papillomavirus in cervical samples by hybrid capture technology. J Clin Virol 2002 0.87
38 Identical human papillomavirus (HPV) genomic variants persist in recurrent respiratory papillomatosis for up to 22 years. J Infect Dis 2012 0.87
39 Novel human papillomavirus type 174 from a cutaneous squamous cell carcinoma. Genome Announc 2013 0.87
40 Hepatitis C virus genotypes in 1,504 patients in Slovenia, 1993-2007. J Med Virol 2009 0.87
41 Hepatitis E virus in domestic pigs and surface waters in Slovenia: prevalence and molecular characterization of a novel genotype 3 lineage. Infect Genet Evol 2011 0.87
42 Unlinked anonymous monitoring of human immunodeficiency virus prevalence in high- and low-risk groups in Slovenia, 1993-2002. Croat Med J 2003 0.86
43 Cervical cancer screening practices in central and eastern Europe in 2012. Acta Dermatovenerol Alp Pannonica Adriat 2013 0.86
44 Cervical cancer burden and prevention activities in Europe. Cancer Epidemiol Biomarkers Prev 2012 0.86
45 Real-time polymerase chain reaction assay based on high-resolution melting analysis for the determination of the rs12979860 polymorphism involved in hepatitis C treatment response. J Virol Methods 2011 0.86
46 Prevaccination genomic diversity of human papillomavirus genotype 6 (HPV 6). Virology 2009 0.85
47 Comparative evaluation of three commercial assays for quantitative measurement of hepatitis B virus DNA in serum samples. Hepatogastroenterology 2002 0.85
48 In inverted papillomas HPV more likely represents incidental colonization than an etiological factor. Virchows Arch 2011 0.85
49 Molecular epidemiology of HIV-1 subtypes based on analysis of pol sequences in Slovenia, 1996-2005. J Med Virol 2006 0.85
50 Evaluation of a commercial real-time PCR assay for quantitation of Epstein-Barr virus DNA in different groups of patients. J Virol Methods 2006 0.85
51 Sinonasal inverted papilloma associated with squamous cell carcinoma. Radiol Oncol 2011 0.85
52 Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia. Eur J Obstet Gynecol Reprod Biol 2009 0.84
53 Detection and differentiation of human papillomavirus genotypes HPV-6 and HPV-11 by FRET-based real-time PCR. J Virol Methods 2008 0.84
54 Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens. J Med Virol 2012 0.84
55 Horizontal transmission of the Leningrad-Zagreb mumps vaccine strain: a report of three cases. Vaccine 2008 0.84
56 The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation. AIDS Res Hum Retroviruses 2012 0.84
57 Prevaccination genomic diversity of human papillomavirus genotype 11: a study on 63 clinical isolates and 10 full-length genome sequences. J Med Virol 2011 0.83
58 Characterization of a novel cutaneous human papillomavirus genotype HPV-125. PLoS One 2011 0.83
59 Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study. Vaccine 2011 0.83
60 HIV-1 subtype B epidemic and transmission patterns in Slovenia. Coll Antropol 2006 0.82
61 Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 2014 0.82
62 Pre-vaccination genomic diversity of human papillomavirus genotype 6 (HPV 6): a comparative analysis of 21 full-length genome sequences. Infect Genet Evol 2011 0.82
63 Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in Europe. PLoS One 2010 0.81
64 Phylogenetic analysis of HIV sequences obtained in a respondent-driven sampling study of men who have sex with men. AIDS Res Hum Retroviruses 2009 0.81
65 Serum antibodies to human papillomavirus (HPV) pseudovirions correlate with natural infection for 13 genital HPV types. J Clin Virol 2013 0.81
66 Telomerase catalytic subunit in laryngeal carcinogenesis--an immunohistochemical study. Mod Pathol 2005 0.81
67 Verrucous carcinoma of the head and neck - not a human papillomavirus-related tumour? J Cell Mol Med 2013 0.81
68 Telomerase reactivation is an early event in laryngeal carcinogenesis. Mod Pathol 2003 0.80
69 [Recent developments in serologic and molecular diagnosis of hepatitis B and C]. Acta Med Croatica 2013 0.79
70 Distribution of HPV genotypes in Slovenian patients with anal carcinoma: preliminary results. Acta Dermatovenerol Alp Pannonica Adriat 2011 0.79
71 [Viralhepatitis. Croatian Consensus Statement 2013]. Acta Med Croatica 2013 0.79
72 Adjuvant therapy for laryngeal papillomatosis. Acta Dermatovenerol Alp Pannonica Adriat 2011 0.79
73 Genomic variants of human papillomavirus genotypes 16, 18, and 33 in women with cervical cancer in Slovenia. J Obstet Gynaecol Res 2010 0.79
74 Evaluation of a new multiplex real-time polymerase chain reaction assay for the detection of human papillomavirus infections in a referral population. Int J Gynecol Cancer 2012 0.79
75 The impact of sleep deprivation and nighttime light exposure on clock gene expression in humans. Croat Med J 2011 0.79
76 Laryngeal Squamous Intraepithelial Lesions: An Updated Review on Etiology, Classification, Molecular Changes, and Treatment. Adv Anat Pathol 2016 0.79
77 Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis. PLoS Med 2015 0.78
78 Prevalence of congenital cytomegalovirus infection in Slovenia: a study on 2,841 newborns. J Med Virol 2011 0.78
79 Prevalence of the Helicobacter pylori babA2 gene and correlation with the degree of gastritis in infected Slovenian children. Antonie Van Leeuwenhoek 2014 0.78
80 Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening program. Vaccine 2013 0.78
81 Does end-stage kidney failure influence hepatitis C progression in hemodialysis patients? Hepatogastroenterology 2003 0.78
82 Genomic diversity of human papillomavirus genotype 53 in an ethnogeographically closed cohort of white European women. J Med Virol 2007 0.78
83 Genomic diversity of human papillomavirus (HPV) genotype 38. J Med Virol 2009 0.78
84 Prevalence of HPV 16 genomic variant carrying a 63 bp duplicated sequence within the E1 gene in Slovenian women. Acta Dermatovenerol Alp Pannonica Adriat 2011 0.78
85 Short communication: prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005-2010. AIDS Res Hum Retroviruses 2012 0.77
86 Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity. Retrovirology 2014 0.77
87 Prevalence of Bartonella infections in Slovenian intravenous drug users. Ann N Y Acad Sci 2003 0.77
88 Cervical cancer screening in Latvia: a brief history and recent improvements (2009-2011). Acta Dermatovenerol Alp Pannonica Adriat 2013 0.77
89 Human papillomaviruses (HPV) in tissue specimens of oral squamous cell papillomas and normal oral mucosa. Anticancer Res 2006 0.77
90 A modified ribavirin-free interferon therapy with boceprevir in post-liver transplant recurrent hepatitis C. J Clin Gastroenterol 2014 0.77
91 Impact of added fluvastatin to standard-of-care treatment on sustained virological response in naïve chronic hepatitis C Patients infected with genotypes 1 and 3. Intervirology 2013 0.77
92 Genetic diversity of HPV-6 in concurrent multiple anogenital warts. Acta Dermatovenerol Alp Pannonica Adriat 2013 0.77
93 Current status of human papillomavirus vaccination implementation in central and eastern Europe. Acta Dermatovenerol Alp Pannonica Adriat 2013 0.77
94 Science without meritocracy. Discrimination among European specialists in infectious diseases and clinical microbiology: a questionnaire survey. BMJ Open 2012 0.76
95 Detection and typing of low-risk human papillomavirus genotypes HPV 6, HPV 11, HPV 42, HPV 43 and HPV 44 by polymerase chain reaction and restriction fragment length polymorphism. J Virol Methods 2010 0.76
96 Frequency of the 32-base pair deletion in the chemokine receptor CCR5 gene is not increased in hepatitis C patients. Gastroenterology 2003 0.76
97 Rapid detection and typing of Molluscum contagiosum virus by FRET-based real-time PCR. J Virol Methods 2012 0.76
98 Clinical features and virologic characteristics of primary and early HIV-1 infection in Slovenian patients. Coll Antropol 2006 0.76
99 Genomic diversity of low-risk human papillomavirus genotypes HPV 40, HPV 42, HPV 43, and HPV 44. J Med Virol 2013 0.76
100 Telomerase catalytic subunit gene expression does not influence survival of patients with squamous cell carcinoma of the larynx and hypopharynx: a case-control study. J Laryngol Otol 2005 0.75
101 Complete Genome Sequence of Phodopus sungorus Papillomavirus Type 1 (PsPV1), a Novel Member of the Pipapillomavirus Genus, Isolated from a Siberian Hamster. Genome Announc 2014 0.75
102 Prevalence of CCR5 Gene 32-Basepair Deletion in Populations of Slavic Origin. Croat Med J 2006 0.75
103 Lack of evidence for hepatitis C virus infection in association with lichen planus. Int J Dermatol 2008 0.75
104 Possible pitfalls in the diagnostic of progressive multifocal leukoencephalopathy. Clin Neuropathol 2016 0.75
105 Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening. J Med Virol 2014 0.75
106 Twenty-four mini-pool HCV RNA screening in a routine clinical virology laboratory setting: a six-year prospective study. J Virol Methods 2010 0.75
107 Persistant immunodominant anti-gag SLYNTVATL responses in HIV-patients with up to 7 years of HAART. Coll Antropol 2006 0.75
108 Genomic distribution of beta papillomaviruses in single eyebrow hair samples and pools of eyebrow hair samples. Acta Dermatovenerol Alp Pannonica Adriat 2011 0.75
109 [HPV genotypes in repeated PAP II smears of group of women in Slovenia]. Med Arh 2006 0.75
110 Human papillomavirus genotype spectrum in studied group of Montenegrin women. Acta Medica (Hradec Kralove) 2012 0.75
111 Twenty-four mini-pool HCV RNA screening outside a blood transfusion setting: results of a 2-year prospective study. J Virol Methods 2006 0.75
112 3rd ESCMID conference on vaccines in Lisbon, Portugal: Vaccines for mutual protection. Hum Vaccin Immunother 2015 0.75
113 Acta Dermatovenerologica Alpina, Pannonica et Adriatica and scientific misconduct. Acta Dermatovenerol Alp Pannonica Adriat 2009 0.75
114 False-positive result of a confirmatory human immunodeficiency virus line immuno assay in an apparently healthy individual--a case report. Coll Antropol 2006 0.75
115 Detection of human papillomavirus genotypes 16/18/45 by hybrid capture hybridisation genotyping probe in clinical specimens: the first report. J Clin Virol 2007 0.75
116 Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients. Wien Klin Wochenschr 2004 0.75
117 Clinical and Demographic Characteristics of Patients with Molluscum Contagiosum Treated at the University Dermatology Clinic Maribor in a 5-year period. Acta Dermatovenerol Croat 2016 0.75
118 Genetic variability of gag and env regions of HIV type 1 strains circulating in Slovenia. AIDS Res Hum Retroviruses 2006 0.75
119 Citation analysis of Acta Dermatovenerologica Alpina, Pannonica et Adriatica: 1992-2011. Acta Dermatovenerol Alp Pannonica Adriat 2012 0.75
120 Early atherosclerosis in HIV-infected patients below the age of 55 years: Slovenian national study. Wien Klin Wochenschr 2014 0.75
121 Citation analysis of Acta Dermatovenerologica Alpina, Pannonica et Adriatica 1992-2008. Acta Dermatovenerol Alp Pannonica Adriat 2009 0.75
122 Yolk sac carcinoma derived from the rat epiblast as a renal isograft. Coll Antropol 2005 0.75
123 Blood-stained letter received by HIV/AIDS reference laboratory in 1993--a historical case report. Coll Antropol 2006 0.75
124 Vaccination indications and limits in the elderly. Acta Dermatovenerol Alp Pannonica Adriat 2013 0.75
125 [Prevalence of human papillomavirus infection in Slovenian women with repeated Pap II smears]. Med Arh 2005 0.75
126 Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor. Wien Klin Wochenschr 2004 0.75
127 TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck. Head Neck 2013 0.75
128 SeptiFast real-time PCR for detection of bloodborne pathogens in patients with severe sepsis or septic shock. Coll Antropol 2014 0.75